otiti
media
om
seriou
healthcar
problem
develop
develop
countri
om
refer
inflamm
area
behind
tympan
membran
call
middl
ear
fig
inflammatori
mediat
gener
om
penetr
middl
inner
ear
potenti
lead
hear
loss
fig
hear
loss
seriou
consequ
especi
childhood
includ
delay
languag
develop
impair
commun
om
account
million
visit
physician
offic
associ
signific
healthcar
cost
om
broadli
classifi
acut
chronic
type
acut
otiti
media
aom
refer
type
swell
tympan
membran
otorrhea
attribut
otiti
externa
fig
typic
present
includ
inflamm
middl
ear
symptom
infect
fig
common
pathogen
associ
aom
includ
streptococcu
pneumonia
nontyp
haemophilu
influenza
nthi
moraxella
case
despit
antimicrobi
therapi
aom
progress
chronic
om
com
frequent
type
com
chronic
suppur
om
csom
character
tympan
membran
perfor
purul
discharg
fig
host
immun
respons
play
crucial
role
provid
protect
infect
includ
om
broadli
two
gener
type
immun
defens
mechan
innat
adapt
immun
respons
compos
uniqu
interrel
cellular
secretori
compon
addit
mechan
chemic
microbiolog
barrier
includ
mucin
product
middl
ear
fig
provid
protect
invad
pathogen
otopathogen
manag
cross
epitheli
barrier
subject
recognit
neutrophil
macrophag
time
howev
innat
immun
system
may
abl
clear
otopathogen
henc
may
requir
lymphocyt
adapt
immun
system
halt
invas
lymphocyt
adapt
immun
system
give
versatil
defens
provid
last
protect
subsequ
reinfect
pathogen
aim
review
articl
summar
immun
respons
present
middl
ear
otopathogen
evad
respons
induc
om
eustachian
tube
epithelium
versatil
function
mechan
chemic
microbiolog
barrier
infect
beyond
epithelium
basic
function
physic
barrier
virtu
tight
junction
epitheli
cell
combin
mechan
action
mucociliari
transport
product
chemic
barrier
epitheli
cell
function
produc
lysozym
combin
mucoid
serou
mucu
adjac
goblet
cell
mixtur
antimicrobi
natur
prevent
epitheli
cell
invas
otopathogen
mucociliari
transport
apparatu
trap
glycoprotein
mucu
ultim
propel
fluid
downward
eustachian
tube
nasopharynx
innat
defens
mechan
prevent
bacteri
viral
pathogen
epitheli
surfac
describ
term
secretori
nonsecretori
natur
importantli
secretori
cell
creat
mucin
lactotransferrin
lysozym
defensin
surfact
secret
foster
balanc
clean
environ
middl
ear
chemic
microbiolog
mechan
henc
flow
antimicrobi
protein
provid
protect
potenti
invas
middl
ear
also
maintain
inher
protect
constitu
includ
defensin
mucin
lysozym
defensin
member
subset
antimicrobi
peptid
amp
defensin
within
middl
ear
play
crucial
role
nonenzymat
inhibit
bacteria
fungi
protozoa
addit
associ
defensin
includ
inhibit
bacteri
toxin
proinflammatori
activ
stimul
cytokin
chemokin
product
well
creation
pore
membran
three
differ
type
defensin
discov
includ
human
express
express
granulocyt
intestin
paneth
first
discov
name
former
function
human
neutrophil
peptid
hnp
six
human
identifi
abbrevi
hnp
express
granul
neutrophil
entail
import
immun
reaction
associ
om
potent
appear
activ
sever
strain
phagocyt
human
hbd
express
within
epitheli
cell
variou
organ
includ
middl
ear
make
perhap
intrins
relat
eustachian
tube
om
although
hbd
discov
hbd
extens
studi
defensin
studi
larg
patient
sampl
vitro
vivo
studi
demonstr
induct
associ
bacteri
infect
middl
ear
mous
mbd
first
note
tubotympanum
experiment
hbd
extens
demonstr
play
role
middl
ear
host
immun
defens
amp
capabl
kill
nthi
pneumonia
inde
presenc
bacteria
within
middl
ear
primari
sourc
increas
level
also
associ
increas
product
nthi
trigger
act
synergist
bacteria
enhanc
express
middl
ear
epitheli
cell
map
kinas
increas
express
mrna
protein
level
demonstr
inflam
middl
ear
mucosa
om
patient
comparison
obtain
normal
addit
proinflammatori
cytokin
transcript
via
activ
signal
pathway
human
middl
ear
epitheli
cell
also
shown
proinflammatori
mediat
final
recombin
human
observ
integr
part
nthi
erad
compromis
biofilm
format
within
middl
addit
defensin
surfact
protein
found
halt
infect
albeit
differ
mechan
function
includ
opson
aggreg
phagocytosi
one
surfact
protein
constitu
liquid
cover
middl
ear
mucos
surfac
deliv
mechan
antimicrobi
effect
invad
demonstr
antimicrobi
activ
also
prevent
biofilm
format
organ
p
surfact
reduc
surfac
tension
within
upper
airway
eustachian
tube
within
chinchilla
model
howev
inhibit
alter
nhti
prolifer
still
lead
dysfunct
eustachian
tube
hypothes
dysfunct
occur
result
decreas
mucociliari
clearanc
diminish
antimicrobi
action
similarli
mucin
aid
propag
mucu
cell
creat
protect
barrier
howev
overproduct
mucin
result
delay
clearanc
om
pathogen
underscor
import
homeostasi
middl
lysozym
slightli
differ
defens
role
primari
function
destroy
bacteria
peptidoglycan
cell
lysozym
target
bacteria
cleav
peptidoglycan
polysaccharid
backbon
essenti
piec
bacteri
cell
well
glycan
frequent
target
host
immun
system
lastli
tlr
found
surfac
mani
epitheli
cell
provid
specif
immun
molecular
pattern
pamp
pamp
typic
uniqu
individu
previous
mention
potenti
invad
travers
epithelium
leukocyt
act
first
line
defens
epithelium
besid
mechan
chemic
microbiolog
barrier
innat
immun
play
crucial
role
provid
protect
pathogen
neutrophil
macrophag
integr
compon
innat
immun
middl
ear
help
kill
cell
function
part
initi
respons
infect
foreign
bodi
within
middl
ear
includ
fibroblast
mast
cell
nk
overal
innat
immun
system
respons
gener
initi
protect
respons
trigger
tlr
lead
product
cytokin
respons
invas
middl
ear
cytokin
result
multipl
outcom
includ
erad
infect
also
lead
chronic
otiti
media
com
often
seen
organ
pseudomona
aeruginosa
staphylococcu
organ
creat
biofilm
paradox
increas
host
inflamm
cytokin
product
result
specif
cytokin
associ
com
includ
tnf
inflammatori
respons
benefici
defend
host
lymph
flow
transport
increas
quantiti
antigen
lymphoid
tissu
antigen
transport
lymphoid
tissu
taken
dendrit
cell
activ
adapt
immun
respons
primari
defens
mechan
mucos
secret
immunoglobulin
iga
demonstr
efficaci
protect
streptococcu
human
buccal
epitheli
cell
well
escherichia
coli
urinari
tract
addit
research
investig
iga
influenc
combat
adher
pneumonia
h
influenza
nasopharynx
specif
appli
om
iga
nasopharynx
found
protect
om
pathogen
inhibit
adher
bacteria
epitheli
cell
also
explain
barrier
less
effect
patient
iga
defici
make
individu
prone
om
b
cell
help
provid
protect
infect
onset
infect
cell
creat
memori
cell
subdivid
cytokin
respond
produc
cell
secret
cell
releas
children
th
cell
demonstr
reduc
inhabit
nasopharynx
pneumonia
h
term
b
cell
respons
primari
antibodi
found
middl
ear
iga
children
fewer
memori
b
cell
found
like
develop
om
demonstr
import
b
cell
immunolog
besid
immunolog
respons
ear
addit
protect
mechan
microbi
colon
defensin
biomolecul
commens
organ
also
provid
protect
ear
infect
observ
although
commens
organ
function
preserv
synchron
organ
perpetu
om
other
may
even
protect
contract
respiratori
tract
infect
urti
exampl
aureu
combat
otopathogen
prevent
nasopharyng
colon
thu
may
inhibit
develop
om
similarli
sphingobium
may
protect
om
wherea
bifidobacterium
limit
influenc
urti
estim
aom
case
preced
either
common
cold
anoth
order
import
viral
infect
includ
respiratori
syncyti
viru
rsv
rhinoviru
adenoviru
coronaviru
bocaviru
influenza
viru
parainfluenza
viru
enteroviru
human
typic
children
asymptomat
bacteri
colon
nasopharynx
howev
viral
infect
initi
inflamm
within
eustachian
tube
although
epithelium
normal
mucociliari
flow
lysozym
protein
readili
elimin
bacteria
normal
circumst
host
protect
stymi
new
viral
induc
inflamm
inflamm
eustachian
tube
precipit
dysfunct
neg
pressur
within
middl
ear
allow
previous
colon
organ
evad
epithelium
normal
defens
neg
pressur
often
occur
greater
sever
children
less
month
old
comparison
children
month
age
although
cytokin
product
often
explain
direct
action
host
immun
system
sever
exampl
suggest
secret
chemokin
cytokin
manipul
otopathogen
enhanc
surviv
exampl
viral
infect
associ
eustachian
tube
dysfunct
least
partial
due
cytokin
product
mediat
inflammatori
respons
recent
hypothes
inflammatori
mediat
could
facilit
bacteri
adher
colon
rise
level
inflamm
number
epitheli
cell
surfac
antigen
increas
mani
known
serv
site
bacteri
increas
level
live
virus
bacteria
middl
ear
associ
mediat
inflammatori
respons
includ
histamin
leukotrien
known
hinder
deliveri
ultim
penetr
cytokin
induc
viral
infect
caus
tissu
damag
make
fertil
ground
bacteri
although
mani
cytokin
appear
induc
viral
infect
potenti
later
manipul
bacteri
pathogen
alway
case
exampl
one
cytokin
known
potent
om
inflamm
effector
also
appear
predominantli
protect
role
mice
model
knockout
mice
shown
higher
pathogen
colon
rate
defect
host
macrophag
result
reduc
abil
host
combat
p
aeruginosa
knowledg
pervas
role
could
help
develop
therapeut
strategi
treat
persist
om
damag
host
mucociliari
transport
system
middl
ear
thought
initi
event
facilit
evas
eustachian
tube
defens
otopathogen
mucu
first
barrier
protect
epithelium
virus
bacteria
secret
goblet
cell
within
middl
ear
epithelium
mucin
form
mucu
layer
satur
cilia
enabl
mucociliari
transport
clearanc
system
eustachian
tube
fig
product
mucin
normal
limit
orific
eustachian
tube
area
immedi
surround
area
normal
physiolog
level
mucin
promot
clearanc
microb
howev
exagger
product
mucu
lead
entrap
bacteria
prevent
clearanc
enhanc
retent
bacteria
lead
om
specif
mucin
also
correl
variou
type
om
exampl
found
common
mucin
involv
om
effus
demonstr
presenc
mucin
mucin
mucin
left
untreat
aom
may
progress
chronic
om
effus
come
specif
nthi
common
bacteri
pathogen
contribut
patholog
although
research
continu
investig
nthi
pathogen
mechan
known
nthi
activ
mucin
transcript
bacteri
cell
initi
step
requir
stimul
transcript
trigger
protein
kinas
convers
neg
feedback
mechan
exist
phosphoinositid
pathway
lead
inactiv
transcript
commun
protein
kinas
ultim
activ
pathway
lead
overabund
mucin
therebi
contribut
conduct
hear
loss
come
decreas
mucociliari
clearanc
increas
bacteri
retent
middl
ear
persist
recent
discov
curcumin
princip
curcuminoid
turmer
curcuma
longa
inhibitor
molecular
mechan
cucurmin
transcript
manipul
transcript
factor
mapk
pathway
cucurmin
abil
imped
express
activ
mapk
studi
warrant
explor
therapeut
potenti
curcumin
om
besid
mucin
mani
bacteri
pathogen
also
abl
use
phase
variat
regul
gene
express
evad
potent
host
immun
respons
fig
though
research
still
attempt
better
elucid
nthi
particular
variou
form
phase
variat
rearrang
modif
glycosyltransferas
gene
allel
onoff
switch
dna
methyltransferas
moda
manipul
polythymidin
tract
hia
nthi
moda
allel
phasevers
studi
anim
model
specif
investig
om
demonstr
anim
phasevers
higher
burden
tetranucleotid
repeat
influenc
phase
variat
gene
also
studi
observ
switch
oafa
gene
provid
overal
benefit
middl
nthi
also
known
hia
transcript
promotor
region
hia
protein
anoth
form
phase
previous
allud
hia
abl
modifi
tract
overal
object
tract
variat
escap
opsonophagocyt
kill
host
immun
system
demonstr
strain
nthi
less
hia
express
success
evas
phase
variat
also
allow
speci
pathogen
manipul
genet
makeup
obtain
nutrient
environ
well
resist
oxid
stress
host
immun
phase
variat
affect
biofilm
format
prolong
format
longer
period
time
lead
immun
system
find
also
suggest
increas
biofilm
format
alkalin
condit
ph
biofilm
form
alkalin
environ
associ
increas
hmw
adhesin
phase
version
also
associ
greater
suscept
oxid
stress
less
resist
protect
oxid
stress
also
seen
om
pathogen
pneumonia
manipul
antioxid
tlpatsa
addit
exampl
host
immun
phase
variat
also
seen
amongst
om
pathogen
three
dna
methyltransferas
modm
allel
found
catarrhali
affect
pathogenesi
phase
variat
pneumonia
specif
transpar
variant
demonstr
differ
host
evas
base
specif
avoid
destruct
hypothes
transpar
variant
specif
enabl
better
adhes
environ
human
experiment
model
tympanostomi
tube
placement
increas
express
nana
hyla
pspa
transpar
variant
variant
also
increas
level
nana
hyla
baselin
suggest
increas
virul
find
suggest
variant
pneumococc
pathogen
respons
pathogenesi
addit
phase
variat
otopathogen
take
advantag
exist
infect
induc
om
phenomenon
typic
involv
viral
coinfect
often
make
om
polymicrobi
common
virus
associ
om
influenza
viru
parainfluenza
viru
rhinoviru
coronaviru
frequent
om
occur
day
viral
coinfect
result
poor
antibiot
respons
hypothes
due
reduc
penetr
middl
ear
addit
theori
inflammatori
mediat
releas
virus
result
delay
resolut
anim
model
shown
polymicrobi
infect
addit
result
hypersecret
increas
viscos
similar
find
seen
among
human
influenza
infect
howev
human
biochem
qualiti
secret
modifi
oppos
chang
occur
simpli
quantiti
viscos
chang
secret
human
mucosa
thought
due
viral
polymicrobi
interact
increas
virul
pathogen
evad
host
respons
biofilm
provid
addit
immunolog
evas
mechan
beyond
increas
bacteri
adher
pathogen
biofilm
found
integr
pathogenesi
biofilm
demonstr
contribut
inabl
host
immun
system
clear
bacteria
specif
biofilm
creat
pneumonia
h
influenza
appear
help
pathogen
avoid
complement
immun
pneumonia
mani
differ
protein
variant
name
pspa
pspc
pht
e
pli
provid
protect
microbi
bacteri
protein
interweav
complex
interplay
reaction
inhibit
complement
adequ
protect
host
exampl
pspa
factor
appear
help
halt
crp
convertas
format
pspc
also
appear
inhibit
convertas
though
differ
target
molecul
includ
fh
vitronectin
final
pli
factor
target
igg
keep
host
complement
system
away
bacteri
cell
virul
peptid
perpetu
biofilm
develop
middl
current
time
hypothes
detect
local
amino
acid
level
howev
precis
molecular
mechan
influenc
biofilm
virul
still
known
besid
bacteri
protein
extracellular
dna
edna
associ
dnabii
hypothes
involv
biofilm
architectur
structur
edna
structur
compon
extracellular
polymer
substanc
edna
stabil
edna
strand
form
meshwork
crisscross
strand
h
influenza
isogen
mutant
demonstr
decreas
presenc
edna
type
iv
pilu
tfp
silico
nonisogen
mutant
howev
demonstr
elev
level
fractal
structur
appear
role
enabl
biofilm
nutrient
exchang
feedback
mechan
extracellular
rna
also
play
import
role
initi
step
biofilm
synthesi
though
overal
function
less
overal
biofilm
synthes
nthi
found
releas
extracellular
dna
addit
edna
genet
associ
relat
biofilm
format
nthi
involv
activ
lipooligosaccharid
lo
locat
surfac
bacteria
phosphorylcholin
pcho
found
lo
found
pcho
aid
stabil
nthi
biofilm
anim
nthi
pathogen
enhanc
mutat
lux
influenc
quorum
signal
pathway
result
develop
well
establish
biofilm
particularli
pathogen
case
om
infect
polymicrobi
henc
creat
synergist
reaction
increas
growth
organ
antimicrobi
toler
increas
virul
persist
well
exagger
level
exopolysaccharid
ep
biofilm
found
associ
adenoid
hypertrophi
middl
ear
syntrophi
may
also
occur
support
idea
growth
one
product
increas
growth
anoth
contribut
infect
elev
specif
exampl
coinfect
nana
influenza
pneumonia
nana
requir
adher
influenza
well
interplay
pathogen
two
glycan
carbohydr
structur
found
surfac
pathogen
host
structur
often
involv
highli
specif
bacteria
present
glycosyl
molecul
host
molecul
includ
polysaccharid
glycoprotein
lo
lp
pathogen
util
glycan
found
surfac
mani
host
cell
sourc
bacteri
toxin
locat
attach
subsequ
one
exampl
h
influenza
shown
obtain
sialic
acid
host
cell
inner
ear
anim
model
sialic
acid
use
catabol
sialyl
pathogen
sialic
acid
catabol
gene
associ
process
nanek
nana
siaa
nagba
demonstr
integr
pathogen
h
chang
bacteri
capsular
structur
often
underli
bacteri
evas
host
immun
respons
case
structur
inhibitori
immun
function
mechan
includ
bacteria
creat
surfac
glycosyl
structur
mimic
host
glycan
mani
case
allow
subvers
host
immun
system
recognit
mechan
help
microb
avoid
immun
defens
macrophag
recognit
particular
util
glycan
surfac
recogn
bacteria
capsular
polysaccharid
also
observ
mimic
glycan
structur
host
common
mechan
illustr
concept
involv
variat
group
streptococcu
ga
capsul
hyaluronan
ha
express
ga
capsul
observ
ha
interact
host
cell
high
molecular
weight
ha
lead
decreas
phagocytosi
macrophag
comparison
low
molecular
weight
ha
lead
increas
macrophag
uptak
bacteria
alter
protein
glycosyl
pattern
avoid
cleavag
host
proteas
nthi
appear
use
glycosyl
protect
high
molecular
weight
adhesin
action
serv
attach
bacteri
surfac
along
protect
degrad
host
nthi
peptidoglycan
associ
outer
membran
protein
omp
serv
ligand
likewis
lo
ligand
one
might
expect
polymorph
associ
omp
lo
found
associ
recurr
case
import
clinic
implic
find
patient
group
chronic
middl
ear
infect
csom
appear
lower
baselin
level
protein
mrna
relat
commens
organ
often
make
use
glycan
interact
host
cell
provid
avoid
neisseria
meningitidi
exampl
pathogen
commens
nasopharynx
estim
n
meningitidi
serogroup
c
conjug
mcc
vaccin
achiev
protect
gener
bactericid
antibodi
target
serogroup
c
even
use
mcc
vaccin
least
three
n
meningitidi
escap
strain
note
n
meningitidi
resist
vaccin
appear
relat
chang
capsular
product
resist
associ
insert
sequenc
lie
within
intergen
region
sia
ctr
operon
addit
result
increas
capsular
polysaccharid
synthesi
asid
vaccin
resist
attain
increas
capsular
product
increas
polysaccharid
also
observ
interfer
complement
activ
sialic
capsul
interfer
complement
cascad
amplif
altern
pathway
inhibit
bacteri
surfac
consequ
decreas
membran
attack
complex
also
observ
although
modif
glycan
locat
surfac
pathogen
assist
aforement
evas
mechan
modif
host
protein
also
note
bacteria
modifi
host
glycan
use
enzym
glycosyltransferas
enzym
commonli
studi
neuraminidas
pneumonia
observ
produc
least
glycosidas
neuraminidas
integr
nutrient
acquisit
pathogenesi
exampl
acetylneuramin
lyas
nana
sialidas
b
nanb
neuramidas
c
nanc
pneumonia
use
enzym
critic
aspect
colon
util
carbon
sourc
host
mucos
surfac
gener
biofilm
architectur
pneumonia
associ
induct
infect
secondari
influenza
influenza
neuraminidas
activ
sialyl
structur
appear
facilit
pneumonia
secondari
method
glycan
modifi
evad
host
immun
system
divers
mechan
includ
use
host
carbohydr
structur
sourc
carbon
target
host
glycan
pathogen
toxin
use
polysaccharid
site
attach
opportun
mimicri
host
molecular
mimicri
via
glycan
modif
impact
either
innat
adapt
immun
function
investig
interact
could
pave
way
develop
futur
therapi
om
pathogen
also
abl
escap
host
defens
manipul
host
innat
immun
system
neutrophil
typic
first
respond
form
neutrophil
extracellular
trap
net
kill
pathogen
aom
anim
model
demonstr
net
fibrin
format
initi
host
defens
middl
ear
howev
persist
net
fibrin
contribut
biofilm
format
henc
chronic
diseas
attribut
fact
net
lead
thicker
effus
creat
fertil
ground
biofilm
end
result
associ
net
com
middl
ear
respiratori
pathogen
pneumonia
aureu
appear
prevent
releas
net
least
part
due
nucleas
imped
antibacteri
protein
break
although
net
extens
studi
pulmonari
diseas
target
role
om
especi
csom
still
clear
warrant
studi
addit
net
eosinophil
extracellular
trap
et
implic
pathogenesi
om
et
associ
eosinophil
om
eom
appear
facilit
releas
eosinophil
granul
well
dna
trap
destroy
eosinophil
mast
cell
contribut
host
cell
immun
often
found
com
eosinophil
middl
ear
activ
cytokin
eotaxin
eventu
eosinophil
undergo
extracellular
trap
cell
death
also
known
etosi
involv
cell
death
result
creation
extracellular
trap
et
play
import
role
eosinophil
mechan
eosinophil
trap
promot
evas
immun
otopathogen
increas
amount
eosinophil
secret
result
increas
increas
viscos
hinder
clearanc
otopathogen
mucocilari
system
also
prevent
penetr
antimicrobi
compound
furthermor
end
product
etosi
expuls
protein
cytokin
chromatin
lipid
mediat
compon
inflamm
perpetu
damag
surround
find
suggest
fibrin
net
et
could
serv
potenti
avenu
therapi
precis
mechan
underli
pathogenesi
com
still
far
clear
need
initi
research
studi
area
studi
start
deciph
molecular
mechan
lead
comcsom
otopathogen
p
aeruginosa
demonstr
activ
pkc
pathway
phosphoryl
lead
invas
human
middl
ear
epitheli
cell
abil
otopathogen
p
aeruginosa
activ
pkc
pathway
depend
oprf
express
result
studi
demonstr
crucial
role
pkc
pathway
oprf
express
play
pathogenesi
pkc
pathway
respons
activ
mani
subsequ
signal
cascad
activ
express
proinflammatori
cytokin
specif
cytokin
contribut
chronic
also
demonstr
otopathogen
p
aeruginosa
enter
multipli
insid
human
mous
primari
macrophag
depend
microtubul
actin
depend
colon
macrophag
otopathogen
p
aeruginosa
lead
evas
potent
immun
respons
may
contribut
persist
infect
observ
csom
comcsom
also
associ
increas
biofilm
format
explain
com
infect
difficult
howev
remain
seen
com
pathogen
p
aeruginosa
aureu
manipul
host
immun
promot
biofilm
format
middl
ear
lead
subvers
immun
respons
induc
infect
apc
tumor
suppressor
gene
delet
also
associ
com
exampl
com
result
abnorm
skin
growth
compos
stratifi
squamou
keratin
epithelium
known
clinic
cholesteatoma
children
cholesteatoma
genet
associ
delet
apc
tumor
suppressor
gene
well
variat
connexin
gene
studi
highlight
need
understand
role
genet
predisposit
comcsom
evas
host
immun
respons
om
one
common
childhood
infect
character
mucu
overproduct
elev
level
inflamm
within
middl
ear
common
pathogen
pneumonia
h
influenza
moraxella
capabl
induc
om
due
complex
interplay
pathogen
host
immun
ultim
lead
evas
potent
immun
respons
wide
varieti
mechan
biofilm
format
phase
variat
glycan
implic
subvers
host
immun
respons
aom
pathogen
biofilm
compos
extracellular
substanc
form
protect
layer
shield
pathogen
host
immun
system
well
intervent
therapi
identif
character
protein
dnabii
type
iv
pili
tfp
led
develop
antibodi
target
structur
subsequ
demonstr
destruct
biofilm
protect
h
although
target
either
protein
independ
subtl
yet
differ
effect
strategi
support
idea
erad
biofilm
format
approach
may
assist
clear
adher
plankton
gener
nthi
although
destruct
biofilm
structur
may
facilit
pathogen
vulner
pharmaceut
intervent
target
intracellular
pathway
also
demonstr
potenti
therapeut
strategi
om
understand
role
host
pathway
mapk
mapk
phosphatas
well
mucin
signal
cascad
natur
compound
curcumin
abl
target
pathway
may
help
develop
novel
treatment
modal
om
investig
therapi
warrant
particularli
focus
increas
local
drug
concentr
improv
target
deliveri
within
middl
ear
addit
biofilm
format
host
pathway
phase
variat
allow
bacteri
pathogen
regul
genet
makeup
escap
destruct
host
immun
system
research
shown
moda
phase
variat
specif
give
nthi
pathogen
abil
evad
host
immun
increas
pathogenesi
research
focus
moda
phase
variat
nthi
may
allow
genet
manipul
prevent
treat
infect
nthi
also
adhesin
type
iv
fimbria
hia
help
protect
host
immun
system
investig
structur
nthi
infect
host
middl
ear
could
use
creat
vaccin
type
vaccin
could
use
prevent
futur
om
infect
synthes
multipl
adhesin
glycan
addit
extracellular
compon
bacteri
pathogen
import
structur
compon
cell
wall
glycan
uniqu
membran
protein
even
acquir
host
cell
due
vari
natur
bacteri
glycan
role
play
evas
host
immun
system
possibl
futur
research
may
allow
modif
glycan
defens
mechan
om
although
number
studi
highlight
molecular
mechan
involv
subvers
immun
respons
aom
knowledg
regard
com
still
limit
despit
high
preval
com
especi
csom
develop
develop
countri
still
underexplor
research
area
urgent
need
perform
research
studi
determin
molecular
mechan
employ
comcsom
pathogen
p
aeruginosa
caus
middl
ear
infect
understand
role
host
immun
cell
net
pathophysiolog
comcsom
provid
novel
insight
pathogenesi
diseas
aspect
immunolog
host
evas
focus
research
integr
mechan
host
evas
resist
like
acceler
overal
knowledg
prevent
treatment
comcsom
avail
novel
effect
treatment
modal
beyond
antibiot
therapi
lead
improv
qualiti
life
mani
om
patient
famili
